ResMed is betting big on artificial intelligence (AI) to boost CPAP adherence. At the recent J.P. Morgan Healthcare Conference, CEO Mick Farrell said the company’s first AI-enabled medical device, Sma ...
Canaday was named chief of staff for the executive team at Resmed in January 2022. Later that year, she moved into the ...
Intrigue Pages - Lifestyle on MSN
10 stocks with solid growth history and a promising outlook
In an era where markets have swung between volatility and structural transformation, growth stocks continue to anchor ...
10d
Smart, Silent, Powerful: Air Voel Highlights the Breakthrough Features of AirSense 11 CPAP Machines
Air Voel is shining a spotlight on the latest generation of sleep apnea therapy with the AirSense 11 CPAP machines, a ...
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( ($AU:RMD) ) has provided an update. An executive of ResMed Inc., officer ...
CPAP therapy can help you decrease snoring and improve your sleep by keeping your airways open. Insurance often covers CPAP machines, which cost between $350 and $3,000. Using a CPAP machine every ...
Technology uses real-world sleep data and machine learning to help people with sleep apnea start and stay on therapy SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
GLP-1 drugs pose an existential threat to CPAP-makers. ResMed is currently experiencing temporary tailwinds before potential long-term headwinds. ResMed (NYSE: RMD) finds itself in an investment limbo ...
ResMed (NYSE: RMD) finds itself in an investment limbo as revolutionary weight loss drugs create both immediate opportunities and long-term existential questions for the sleep apnea device maker. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback